Meridian Life Science, Inc.
5171 Wilfong Road
Memphis
Tennessee
38134
United States
Tel: 901-382-8716
Website: http://www.meridianlifescience.com/
Email: info@meridianlifescience.com
About Meridian Life Science, Inc.
Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori., foodborne diseases. and respiratory infections.
For more than 30 years, Meridian Bioscience, Inc., has established a proven track record of profitable growth and product launches designed to enhance patient well being while reducing the total outcome costs of healthcare. Meridian diagnostic products are used outside of the human body and require little or no special equipment.
We maintain market leadership by responding to emerging diseases and changing medical needs. Since 1991, Meridian has developed and introduced more than 56 innovative products. Meridian also grows through acquisition, licensing, or supply agreements that have added almost 100 new products to our catalog.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. We actively market our products to hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.
Our shares are traded on the NASDAQ National Market, symbol VIVO.
192 articles about Meridian Life Science, Inc.
-
Meridian Bioscience, Inc. to Present at the Robert W. Baird 2008 Small Cap Healthcare Conference
9/5/2008
-
Meridian Bioscience, Inc. Provides Sales and Earnings Guidance for Fiscal 2009 and Reaffirms Fiscal 2008 Guidance
8/14/2008
-
Meridian Bioscience, Inc. Reports Record Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2008 Guidance, and Comments on Fiscal 2009 Outlook
7/17/2008
-
Meridian Bioscience, Inc. Completes Acquisition of Recombinant Protein Technologies and Products from Vybion, Inc.
6/19/2008
-
Vybion, Inc. Signs Agreement in Principle to Sell Line of Recombinant Proteins to Meridian Bioscience, Inc.
5/13/2008
-
Meridian Bioscience, Inc. to Present At the Nasdaq 21st Investor Program, London
5/13/2008
-
Meridian Bioscience, Inc. to Present at the Robert W. Baird 2008 Growth Stock Conference
5/12/2008
-
Meridian Bioscience, Inc. Reports Record Second Quarter and Six Months Operating Results
4/17/2008
-
Meridian Bioscience, Inc. Launches Two New TRU(TM) Brand Rapid Tests for the Detection of Epstein-Barr Virus
4/10/2008
-
Meridian Bioscience, Inc. to Present at the Sidoti & Company, LLC Twelfth Annual New York Emerging Growth Institutional Investor Forum
3/25/2008
-
Meridian Bioscience, Inc. Names CEO
1/29/2008
-
Meridian Bioscience, Inc. Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2008 Guidance
1/22/2008
-
Meridian Bioscience, Inc. Receives FDA Clearance for Two New Rapid Tests for the Detection of Influenza and Respiratory Syncytial Virus
11/26/2007
-
Meridian Bioscience, Inc. Reports Record Fiscal 2007 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
11/14/2007
-
Meridian Bioscience, Inc. to Present at the UBS Warburg Global Life Science Conference
9/20/2007
-
Meridian Bioscience, Inc. to Present at the Sidoti & Company, LLC Sixth Annual West Coast Emerging Growth International Investor Forum
9/19/2007
-
Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine
8/28/2007
-
Meridian Bioscience, Inc. Provides Sales and Earnings Guidance for Fiscal 2008 and Reaffirms Fiscal 2007 Guidance
8/14/2007
-
Meridian Bioscience, Inc. Awarded National Institutes of Health (NIH) Contract for Production of Experimental Vaccines; Up to $12.2 Million
8/7/2007
-
Meridian Bioscience, Inc. Director Sells Stock
7/23/2007